Jiangsu Lianhuan Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 943.37 million compared to CNY 889.63 million a year ago. Revenue was CNY 954.65 million compared to CNY 896.69 million a year ago.

Net income was CNY 61.53 million compared to CNY 65.66 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.23 a year ago. Diluted earnings per share from continuing operations was CNY 0.21 compared to CNY 0.23 a year ago.